Research Advances and Obstacles of CT-based Radiomics in Diagnosis and Treatment of Lung Cancer.
10.3779/j.issn.1009-3419.2020.101.36
- Author:
Jiawei LI
1
;
Xiadong LI
2
;
Xueqin CHEN
3
;
Shenglin MA
3
Author Information
1. Zhejiang Chinese Medical University, Hangzhou 310053, China.
2. Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, China.
3. Department of Oncology, Hangzhou First People's Hospital, Hangzhou 310006, China.
- Publication Type:Journal Article
- Keywords:
Biomarkers;
Computed Tomography;
Lung neoplasms;
Prognosis;
Radiomics
- From:
Chinese Journal of Lung Cancer
2020;23(10):904-908
- CountryChina
- Language:Chinese
-
Abstract:
Radiomics, a technology based on multimodal medical image processing and analysis, is able to extract automatically and analyze massive data from computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) via high-performance computer algorithm in order to pursue early diagnosis of disease, benign and malignant tumor discrimination, dynamic evaluation of disease treatment, and individualized precision therapy. To date, many studies demonstrate that radiomics not only has great potential in early diagnosis of lung cancer and prediction of genotype, treatment efficacy, as well as prognosis but also is based on imaging methods that are noninvasive, inexpensive, and repeatable. It does demonstrate precious values in guiding the clinical diagnosis and treatment of lung cancer, especially in the personalized and precise treatments and researches of lung cancer. However, the consistency and reproducibility of radiomics and the selection of robust characteristics still warrant further researches.
.
